Clinical trial
A Co-clinical Trial in Triple Negative Breast Cancer Patients With Genoproteomic Discovery
NCT02124902 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Co-clinical Trial in Triple Negative Breast Cancer Patients With Genoproteomic Discovery
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 7, 2014
- Completion date
- December 31, 2021
- Enrollment
- 148 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.